Comparison 3. Boswellia serrata (enriched) 250 mg versus placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Pain VAS 0‐100 at 90 days | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
2 WOMAC‐VAS (Function) | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
3 Adverse event episodes (n) reported | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected |